2 April 2026

Osteoarthritis Research

Low value care in knee OA to be put under the microscope

2 April 2026

Clinical research Pharmaceuticals Polymyalgia Rheumatica

Secukinumab boosts remission in PMR

2 April 2026

Axial spondyloarthritis Biologics Clinical research

Bimekizumab safety holds up with longer-term data

2 April 2026

Clinical research Dermatomyositis

Brepocitinib shows promise in phase 3 dermatomyositis trial

19 March 2026

Clinical research Psoriatic Athritis

GLP-1 RAs linked to lower PsA risk

19 March 2026

Lupus Pharmaceuticals

More evidence for obinutuzumab in lupus patients

19 March 2026

Biologics Psoriatic Athritis

Bimekizumab and risankizumab go head-to-head

19 March 2026

FDA Psoriatic Athritis

New oral option for psoriatic arthritis wins FDA nod

5 March 2026

Pharmaceuticals Plaque psoriasis

Bimekizumab still superior at three years

5 March 2026

Biologics Lupus

Real-world lupus study shows rapid response to anifrolumab

5 March 2026

ACR EULAR Rheumatoid Arthritis

Pred habit not forever in early RA

5 March 2026

Gout Rheumatoid Arthritis

RA and gout: no longer ships in the night?

19 February 2026

Exercise Osteoarthritis Rheumatology

Exercise benefits in osteoarthritis ‘minimal and short-lived’

19 February 2026

Immunology Lupus

CAR-T paper takes it up a notch

19 February 2026

giant cell arteritis Research Rheumatology

The unseen burden of giant cell arteritis

5 February 2026

Biologics Rheumatoid Arthritis

Abatacept delays rheumatoid arthritis onset